Professor Robert Lustig is speaking at Emery Pharma's speaker series.

"Good food is medicine. Bad food needs medicine" Robert Lustig

Robert H. Lustig, M.D. is Professor of Pediatrics in the Division of Endocrinology at University of California, San Francisco, and Director of the Weight Assessment for Teen and Child Health (WATCH) Program at UCSF.

Professor Robert H. Lustig has made significant contributions to society through his research and advocacy focused on the impact of sugar consumption on human health. He is a prominent endocrinologist and pediatrician known for his work on the adverse effects of added sugars, particularly fructose, on metabolic health and the development of chronic diseases.

Lustig's research has shed light on the role of excessive sugar intake in the obesity epidemic and its connection to conditions such as diabetes, heart disease, and fatty liver disease. He has highlighted the harmful effects of sugar on various aspects of human physiology, including subcellular pathologies, insulin resistance, and the promotion of de novo lipogenesis, which contributes to the accumulation of fat in the body.

Through his lectures, public appearances, and advocacy efforts, Lustig has raised awareness about the detrimental effects of sugar on human health and has advocated for policies to reduce sugar consumption. He has emphasized the importance of recognizing added sugars as a primary contributor to chronic diseases and has called for measures to address the sugar-laden food environment and improve public health.

Lustig is also known for his concept of "The Hateful or Grateful Eight," which refers to the eight factors that contribute to metabolic syndrome, a cluster of conditions associated with increased risk of chronic diseases. He has provided insights into the role of nutrition, including sugar, in the development and prevention of metabolic syndrome.

Overall, Professor Robert Lustig has made substantial contributions to society by advancing our understanding of the negative impact of sugar on human health and advocating for changes in public policy and individual behaviors to promote metabolic health and prevent chronic diseases.

we encourage you to watch other video's recorded at Emery Pharma with Professor Lustig:
   • The Subcellular Processes That Belie ...  
   • Professor Lustig’s Hateful - Grateful...  
   • Non-Alcoholic Fatty Liver Disease and...  

About Emery Pharma:
Emery Pharma is a full-service contract research laboratory, supporting the end-to-end development of small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.

Emery Pharma's premium services include analytical, bioanalytical solutions, microbiology & cell biology services, drug and impurity characterization, and general R&D and cGMP/GLP support.

At Emery Pharma, our focus is to find innovative solutions for our Clients’ toughest challenges and tailoring those solutions to fit each Client’s unique needs. Our experienced scientific team will manage the process: from drug discovery, proof-of-concept, data management, data analysis, to gathering insights. The team excels at solving scientific challenges, and addressing any issues early in the process, so Clients don’t experience unnecessary setbacks.

Emery Pharma’s experienced chemists and biologists deploy state-of-the-art technology. Instrumentation ranges from high-resolution mass spec (Orbitrap), Triple quad LC-MS/MS, GC-MS, Preparative HPLC, and 400 MHz multinuclear NMR.

Contact us: [email protected]
https://emerypharma.com/

keywords:
Professor Lustig
Robery Lustig
Emery Pharma
UCSF Grand Rounds
Sugar and fructose
Chronic disease
Medicare
Obesity epidemic
Diabetes
Heart disease
Fatty liver disease
Subcellular pathologies
The hateful or grateful eight
Quentin Tarantino
Diabetic agents
Prevention
Risk factors
Metabolic syndrome
Metabolic health
Mental health
Mitochondria
LDL
Serum triglyceride
De novo lipogenesis